Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine zipper and EF-hand containing transmembrane protein 2 (LETM2) is a mitochondrial inner membrane protein, structurally characterized by a conserved LETM1 domain, a transmembrane segment, a leucine zipper motif, and a C-terminal EF-hand domain[2][5]. In mammals, LETM2 is predicted to function as a transmembrane transporter involved in mitochondrial calcium ion transmembrane transport and mitochondrial organization[2][4][5]. LETM2 shares homology with LETM1, but is less studied; mammalian LETM2 is noted for its restricted expression in testis and sperm, suggesting a specialized physiological role, possibly in spermatogenesis[3]. In plants (Arabidopsis), LETM2 orthologs are essential for efficient mitochondrial protein translation and for normal mitochondrial function and development[1]. There are no known clinically relevant small-molecule drugs or established disease associations for human LETM2, and its role as a therapeutic target has not been established[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper and EF-hand containing transmembrane protein 2 (LETM2).